Diabetic Therapy Market by Product [Injectables (Insulin, Glucagon-like Peptide-1 (GLP-1) Receptor Agonists, and Amylinomimetic Drugs) and Oral-antidiabetic Drugs (OAD) (Biguanides, Sulfonylureas, Thiazolidinediones, Alpha-glucosidase Inhibitors, Dipeptidyl Peptidase IV (DPP-4) Inhibitors, Meglitinides, and Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors)], and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The Diabetic Therapy market size is projected to reach a CAGR of 17% from 2022 to 2028.
Diabetes is a medical condition that arise due to the inability of the body to contain and alter the blood sugar levels as per the needs. This occurs either due to decreased secretion of insulin by the pancreas or could also occur due to the genetic disorder. The major therapy used for the treatment is gene therapy.
Increased incidents of diabetes along with the recent development in the sector are some of the factors that have supported long-term expansion for Diabetic Therapy Market.
North America is the most rapidly growing market and offers a huge opportunity for the automotive industry, whose growth is driven by the increased investments in the sector and also the favourable governmental policies.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Growth Rate |
CAGR of 17% during the forecasting period, 2022-2028 |
Historical Data |
2019-2020 |
Forecast Years |
2022-2028 |
Base Year |
2021 |
Units Considered |
Revenue in USD billion and CAGR from 2022 to 2028 |
Report Segmentation |
Product and region. |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk, Sanofi S.A., and Takeda Pharmaceutical Company Limited |
Available Customization |
In addition to the market data for Diabetic Therapy Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Diabetic Therapy Market is segmented into product and region.